Rajiv Patni Reata Pharmaceuticals Inc (RETA) insider trading activity
Rajiv Patni is EVP, Chief R&D Officer of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of RETA, which is worth approximately $0. The most recent transaction as insider was on Sep 26, 2023, when has been sold 45,000 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Rajiv Patni Transaction History
Also insider at
RP
Rajiv Patni
EVP, Chief R&D Officer
Plano, TX